Evaluation of piggyBac‐mediated anti‐CD19 CAR‐T cells after ex vivo expansion with aAPCs or magnetic beads

Adoptive immunotherapy is a new potential method of tumour therapy, among which anti‐CD19 chimeric antigen receptor T‐cell therapy (CAR‐T cell), is a typical treatment agent for haematological malignancies. Previous clinical trials showed that the quality and phenotype of CAR‐T cells expanded ex viv...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Li‐Rong, Li, Lin, Meng, Ming‐Yao, Wang, Wen‐Ju, Yang, Song‐Lin, Zhao, Yi‐Yi, Wang, Run‐Qing, Gao, Hui, Tang, Wei‐Wei, Yang, Yang, Yang, Li‐Li, Liao, Li‐Wei, Hou, Zong‐Liu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812273/
https://www.ncbi.nlm.nih.gov/pubmed/33225580
http://dx.doi.org/10.1111/jcmm.16118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7812273/
https://www.ncbi.nlm.nih.gov/pubmed/33225580
http://dx.doi.org/10.1111/jcmm.16118

Ejemplares similares